Duncan McKechnie
Executive Vice President and Chief Commercial Officer
Duncan joined Vertex in 2013. As Vertex’s Executive Vice President and Chief Commercial Officer (CCO), he oversees Vertex’s global commercial team, which includes activities that support the approved use of Vertex’s marketed medicines around the world. Prior to becoming CCO, he led the North America Commercial team and oversaw Marketing, Sales, Market Access and Patient Support in the United States and Canada. He also held leadership responsibility for the Global Health Economics and Global Pricing and Market Access functions across the Vertex portfolio.
He graduated with a degree in business studies from the University of Plymouth in the United Kingdom, and prior to Vertex, he held multiple commercial leadership roles of increasing responsibility at Novartis where he worked for over 13 years in the UK, Switzerland and the U.S.
Duncan joined Vertex in 2013. As Vertex’s Executive Vice President and Chief Commercial Officer (CCO), he oversees Vertex’s global commercial team, which includes activities that support the approved use of Vertex’s marketed medicines around the world. Prior to becoming CCO, he led the North America Commercial team and oversaw Marketing, Sales, Market Access and Patient Support in the United States and Canada. He also held leadership responsibility for the Global Health Economics and Global Pricing and Market Access functions across the Vertex portfolio.
He graduated with a degree in business studies from the University of Plymouth in the United Kingdom, and prior to Vertex, he held multiple commercial leadership roles of increasing responsibility at Novartis where he worked for over 13 years in the UK, Switzerland and the U.S.